Bonan Chen

1.8k total citations · 2 hit papers
43 papers, 960 citations indexed

About

Bonan Chen is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Bonan Chen has authored 43 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 10 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Bonan Chen's work include RNA modifications and cancer (5 papers), Autophagy in Disease and Therapy (5 papers) and Ferroptosis and cancer prognosis (4 papers). Bonan Chen is often cited by papers focused on RNA modifications and cancer (5 papers), Autophagy in Disease and Therapy (5 papers) and Ferroptosis and cancer prognosis (4 papers). Bonan Chen collaborates with scholars based in China, Hong Kong and United States. Bonan Chen's co-authors include Wei Kang, Ka‐Fai To, Jun Yu, Yujuan Zhan, Jianyong Xiao, Fuda Xie, Kun Wang, Wai Nok Chan, Kwok Wai Lo and Peiyao Yu and has published in prestigious journals such as Cancer Research, Oncogene and Scientific Reports.

In The Last Decade

Bonan Chen

39 papers receiving 949 citations

Hit Papers

Cellular zinc metabolism and zinc signaling: from biologi... 2024 2026 2025 2024 2025 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bonan Chen China 18 529 179 151 146 117 43 960
Tariq A. Bhat India 14 421 0.8× 141 0.8× 102 0.7× 174 1.2× 109 0.9× 37 921
Qiao Yang China 19 484 0.9× 131 0.7× 136 0.9× 174 1.2× 158 1.4× 48 1.1k
Bilal Rah India 20 653 1.2× 199 1.1× 238 1.6× 122 0.8× 115 1.0× 47 1.2k
Rajan Radha Rasmi India 9 418 0.8× 189 1.1× 131 0.9× 139 1.0× 146 1.2× 20 858
Jin‐Nyoung Ho South Korea 18 482 0.9× 105 0.6× 137 0.9× 116 0.8× 91 0.8× 51 924
Min He China 22 602 1.1× 322 1.8× 105 0.7× 90 0.6× 151 1.3× 76 1.1k
Alexander A. Terentiev Russia 13 457 0.9× 208 1.2× 113 0.7× 68 0.5× 102 0.9× 25 1.1k
Lizhu Lin China 19 633 1.2× 202 1.1× 255 1.7× 177 1.2× 92 0.8× 75 1.2k
Xuhui Tong China 9 650 1.2× 238 1.3× 139 0.9× 260 1.8× 90 0.8× 16 1.1k

Countries citing papers authored by Bonan Chen

Since Specialization
Citations

This map shows the geographic impact of Bonan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bonan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bonan Chen more than expected).

Fields of papers citing papers by Bonan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bonan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bonan Chen. The network helps show where Bonan Chen may publish in the future.

Co-authorship network of co-authors of Bonan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Bonan Chen. A scholar is included among the top collaborators of Bonan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bonan Chen. Bonan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Fuda, Yang Lyu, Bonan Chen, et al.. (2025). The arginine metabolism and its deprivation in cancer therapy. Cancer Letters. 620. 217680–217680. 17 indexed citations breakdown →
2.
Chen, Bonan, Jialin Wu, Guoming Chen, et al.. (2025). Antibody–drug conjugates in cancer therapy: current landscape, challenges, and future directions. Molecular Cancer. 24(1). 279–279. 1 indexed citations
3.
Deng, Xinyi, Junyang Luo, Zaibo Jiang, et al.. (2025). Update in the treatment of cirrhotic patients with portal vein thrombosis. Clinical and Molecular Hepatology. 31(4). 1139–1166.
4.
Deng, Chuangzhong, Jingya Liu, Jing Li, et al.. (2025). Spatial Transcriptional Dynamics of CD74⁺ B Cells in Tertiary Lymphoid Structures Drive Immune Evolution in Penile Squamous Cell Carcinoma. Advanced Science. 12(44). e09742–e09742.
5.
Chen, Guoming, Bonan Chen, Zilan Zhong, et al.. (2025). Bridging the tumor microenvironment: the pivotal role of cancer-associated fibroblasts in tumor cachexia development. Molecular Cancer. 24(1). 194–194.
6.
Chen, Guo-Ming, Qing Ren, Zilan Zhong, et al.. (2024). Exploring the gut microbiome’s role in colorectal cancer: diagnostic and prognostic implications. Frontiers in Immunology. 15. 1431747–1431747. 14 indexed citations
7.
Guan, Xiaoqing, Yichao Wang, Wen-Kai Yu, et al.. (2024). Blocking Ubiquitin‐Specific Protease 7 Induces Ferroptosis in Gastric Cancer via Targeting Stearoyl‐CoA Desaturase. Advanced Science. 11(18). e2307899–e2307899. 39 indexed citations
8.
Chen, Bonan, et al.. (2024). Gentiopicroside improves NASH and liver fibrosis by suppressing TLR4 and NLRP3 signaling pathways. Biomedicine & Pharmacotherapy. 177. 116952–116952. 11 indexed citations
9.
Cheung, Alvin H.K., Xiaoli Liu, Fenfen Ji, et al.. (2023). MLK4 promotes glucose metabolism in lung adenocarcinoma through CREB-mediated activation of phosphoenolpyruvate carboxykinase and is regulated by KLF5. Oncogenesis. 12(1). 35–35. 6 indexed citations
10.
Xie, Fuda, Bonan Chen, Peiyao Yu, et al.. (2023). Updated Epidemiology of Gastric Cancer in Asia: Decreased Incidence but Still a Big Challenge. Cancers. 15(9). 2639–2639. 56 indexed citations
11.
Xie, Fuda, Bonan Chen, Wei Chen, et al.. (2023). The nerve cells in gastrointestinal cancers: from molecular mechanisms to clinical intervention. Oncogene. 43(2). 77–91. 14 indexed citations
12.
13.
Zhu, Qikui, Jie Pan, Bonan Chen, et al.. (2023). An updated meta-analysis of Chinese herbal medicine for the prevention of COVID-19 based on Western-Eastern medicine. Frontiers in Pharmacology. 14. 1257345–1257345. 8 indexed citations
14.
Xie, Fuda, et al.. (2023). Pathway network-based quantitative modeling of the time-dependent and dose-response anti-inflammatory effect of Reduning Injection. Journal of Ethnopharmacology. 307. 116216–116216. 2 indexed citations
15.
Zhang, Yigan, Yanbin Dong, Shuwen Chen, et al.. (2023). Emerging roles of RNA ac4C modification and NAT10 in mammalian development and human diseases. Pharmacology & Therapeutics. 253. 108576–108576. 48 indexed citations
16.
Cheung, Alvin H.K., Bonan Chen, Wai Nok Chan, et al.. (2022). Cancer‐associated fibroblasts in nonsmall cell lung cancer: From molecular mechanisms to clinical implications. International Journal of Cancer. 151(8). 1195–1215. 46 indexed citations
17.
Chan, Wai Nok, Bonan Chen, Alvin H.K. Cheung, et al.. (2022). Targeting YAP1/TAZ in nonsmall‐cell lung carcinoma: From molecular mechanisms to precision medicine. International Journal of Cancer. 152(4). 558–571. 12 indexed citations
18.
Cheung, Alvin H.K., et al.. (2022). Out of the cycle: Impact of cell cycle aberrations on cancer metabolism and metastasis. International Journal of Cancer. 152(8). 1510–1525. 17 indexed citations
19.
Liu, Xiaoli, Yifei Wang, Bonan Chen, et al.. (2022). Targeting the Hippo Pathway in Gastric Cancer and Other Malignancies in the Digestive System: From Bench to Bedside. Biomedicines. 10(10). 2512–2512. 18 indexed citations
20.
Wang, Kun, Qing Gong, Yujuan Zhan, et al.. (2020). Blockage of Autophagic Flux and Induction of Mitochondria Fragmentation by Paroxetine Hydrochloride in Lung Cancer Cells Promotes Apoptosis via the ROS-MAPK Pathway. Frontiers in Cell and Developmental Biology. 7. 397–397. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026